Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should KnowZacks Investment Research • 08/14/26
Quest Diagnostics typically performs between 30 and 40 cyclospora tests a day. Now it's processing more than 1,500.WSJ • 08/05/26
Quest Diagnostics Raises 2026 Outlook as Testing Demand AcceleratesZacks Investment Research • 08/03/26
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?Zacks Investment Research • 07/31/26
Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026Zacks Investment Research • 07/30/26
Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest DiagnosticsPRNewsWire • 07/30/26
Are You Looking for a Top Momentum Pick? Why Quest Diagnostics (DGX) is a Great ChoiceZacks Investment Research • 07/24/26
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?Zacks Investment Research • 07/24/26
Quest Diagnostics Upgrades EPS Outlook For 2026 After Outperforming Q2 ResultsSeeking Alpha • 07/24/26
Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is WinningBenzinga • 07/23/26
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/23/26
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026PRNewsWire • 07/23/26
5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026Zacks Investment Research • 07/21/26
Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in FocusZacks Investment Research • 07/14/26
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPIPRNewsWire • 07/08/26